Now I have verified all the key claims against the paper. Let me write the final consolidated review.

---

## Summary

This paper proposes a pipeline (BDSB) to enhance 3T BOLD fMRI signals to approximate 7T quality, using conformal mapping to project cortical surfaces onto 2D brain disks followed by an unpaired Schrödinger Bridge diffusion model. The method is evaluated on three experimental designs (synthetic NSD, cross-dataset NOD/NSD, paired TDM) and compared against five baselines. The core idea — combining geometric surface parameterization with a generative bridge model for fMRI enhancement — is novel and well-motivated.

## Strengths

1. **Novel pipeline combining conformal surface parameterization with an unpaired Schrödinger Bridge for fMRI enhancement.** Sections 2.2–2.3 describe how the authors map 3D cortical surfaces to 2D brain disks via conformal mapping, then apply BDSB to translate 3T signals toward 7T quality. The ablation study (Table 3) confirms that conformal mapping is critical: SSIM 0.855 vs. 0.833 for harmonic mapping and 0.237 for direct slicing. This geometric alignment step is a genuine methodological contribution.

2. **Consistent improvements over five baselines across multiple experiments.** Table 2 shows that the proposed method achieves the best results on the majority of metrics across synthetic (SSIM 0.855, PSNR 25.05, FID 42.88, R̄² 24.00), cross-dataset real (FID 70.65, R̄² 25.91), and TDM real experiments (PSNR 19.24, FID 62.09). The improvements over Cycle-GAN, OTT-GAN, OTE-GAN, SCR-Net, and fast-DDPM are consistent and often substantial.

3. **Downstream pRF analysis demonstrates functional utility beyond image-level metrics.** Figures 6 and 7 show that enhanced 3T signals yield higher R² values and more stable receptive-center estimates. Figure 7(a) provides a visual comparison of R² distributions against ground-truth 7T data, showing that enhanced data shifts toward the identity line. This links the enhancement to a meaningful neuroimaging task.

4. **Multi-dataset validation with honest acknowledgment of limitations.** The paper designs three distinct experiments (synthetic, cross-dataset, paired TDM) and explicitly discusses the scarcity of paired 3T/7T data (Section 4, "Lack of Paired Data"). The transparency about the TDM dataset's limitations (2 subjects, single session) is commendable.

## Weaknesses

### Major

1. **Missing ground-truth 7T R̄² comparison in the synthetic experiment.** The central claim in the abstract and conclusion is that enhanced 3T data achieves quality "comparable to 7T." In the synthetic experiment, ground-truth 7T data exists and is used as the HQ target. Yet Table 2 reports no R̄² column for the ground-truth 7T data. The reader cannot tell whether the reported R̄²=24.00 from enhanced data actually closes the gap to the true 7T R̄² (which could be, say, 30 or 35). Figure 7(a) provides a qualitative scatter plot, but no quantitative summary of the 7T R̄² distribution is given. Without this number, the paper's central claim is unsubstantiated by the primary metric used to support it. This is the single most impactful gap in the evaluation.

2. **Unexplained FID trade-off in the ablation study.** Table 3 shows that the unregularized conformal mapping variant achieves FID=34.23, while adding regularization (PatchNCE + BD-SSIM) worsens FID to 42.88 — a 25% relative degradation. The paper attributes this to "structural consistency" but does not discuss this trade-off. If the goal is to best approximate the 7T distribution (as FID measures), regularization hurts. Meanwhile, R̄² improves from 22.02 to 24.00, which could reflect the enhanced data becoming more pRF-model-friendly rather than more faithful to true 7T signals. This tension is not acknowledged.

### Minor

3. **No error bars or statistical significance reported.** Table 2 reports only point estimates for all metrics across all experiments. Given the small dataset sizes (especially TDM with 2 subjects) and the inherent variability in fMRI, reporting standard deviations, confidence intervals, or significance tests would substantially strengthen the evaluation.

4. **TDM real experiment yields mixed results on a very small sample.** The paper honestly acknowledges that TDM has only 2 subjects with a single session each. However, the results show that OTT-GAN achieves better SSIM (0.727 vs. 0.718) than the proposed method, and PSNR is nearly tied (19.18 vs. 19.24). The proposed method wins on FID only. Coupled with the tiny sample size, this experiment provides limited support for the paper's claims.

5. **Cross-dataset real experiment lacks external validation of pRF quality.** The paper reports higher R̄² on enhanced NOD data (25.91 vs. 20.26 raw), but R² measures how well a Gaussian pRF model explains the enhanced time series — not whether the enhanced signals are biologically more accurate. No external validation (e.g., comparison to retinotopic atlases, anatomical constraints, or test-retest reliability) is provided. The paper acknowledges the absence of ground truth, but the R² improvement alone is not strong evidence of enhanced signal fidelity.

### Trivial

6. **Computational cost is not discussed.** For a method intended to broaden access to high-quality fMRI, training and inference time matters. The paper does not report runtimes, GPU hours, or model size.

## Nice-to-Haves

- Computing the ground-truth 7T R̄² for the synthetic experiment and reporting it alongside the other results in Table 2 would directly address the most significant gap.
- Validating enhanced pRF maps on real 3T data using anatomical constraints (e.g., comparing angular/eccentricity gradient smoothness to a standard retinotopic atlas like Benson et al. 2014) would provide domain-specific evidence of fidelity.
- On the TDM data, reporting per-subject and per-run results with confidence intervals would clarify whether the method's improvements are robust within the limited sample.

## Removed Points

These points are flagged to be removed, treat them with caution:

- **Baseline tuning concern ("It is unclear whether baseline models were systematically tuned")**: This is speculation about the review process, not a verifiable weakness in the paper as written. The paper states baseline details are in the supplementary material, which was stripped by the parser.
- **Missing hyperparameters / appendix content**: The parser strips appendices from all papers. Criticisms about missing appendix content are not valid.
- **Synthetic data realism**: The paper explicitly discusses this limitation in Section 4 ("Synthetic Data"). The concern is already acknowledged.
- **Claim about "first approach"**: The harsh critic questions whether this is truly the first, but only speculates without citing a specific prior work. Per the rules, I cannot introduce missing related works.
- **Pure formatting/style nitpicks and typo-level criticisms**: These are parser artifacts, not author errors.
- **Strength Finder's generic/superficial strengths**: Claims like "the paper is well-structured" or "the problem is important" are dropped as they lack specific evidence.

## Novel Insights

None beyond the paper's own contributions. The reviews surface an important evaluation-design tension: when the central metric (R²) measures within-model fit rather than ground-truth fidelity, improvement can arise from making data more pRF-model-friendly rather than more accurate. This is a general concern for any method that uses a downstream model's fit as a proxy for data quality, and the paper would benefit from explicitly addressing this confound.

## Suggestions

1. **Report the ground-truth 7T R̄² in Table 2 for the synthetic experiment.** This is the single most impactful fix. If the enhanced R̄² approaches or reaches the 7T value, the central claim is supported. If not, the claims should be tempered accordingly.

2. **Discuss the FID/R̄² trade-off in the ablation.** Explain why regularization improves R² and PSNR while degrading FID, and whether this trade-off is expected or concerning.

3. **Add error bars to all quantitative results.** Even bootstrapped confidence intervals for the metrics in Table 2 would be a significant improvement.

4. **Add a validation experiment on the cross-dataset real data** using an external criterion — e.g., comparing the spatial gradients of angle/eccentricity maps from enhanced data to a retinotopic atlas, or measuring test-retest reliability across runs.

5. **Temper the abstract and conclusion claims.** Change "comparable to 7T quality" to something like "substantially improved over raw 3T, approaching 7T quality on several metrics" unless the ground-truth R̄² comparison can be added and confirms the stronger claim.

## Score and Decision

**Calibration.** I performed three rounds of retrieval against the human-review corpus.

**Round 1 (bracketing):** Three queries on "fMRI enhancement 3T 7T diffusion model Schrödinger bridge" with score bands (−∞, 3.5), (3.5, 7.5), (7.5, ∞). The low band returned papers at 2.33–3.40 (fMRI decoding/reconstruction papers with serious flaws). The mid band returned papers at 3.75–6.60 (MindSimulator at 5.75, Fast Ensembling at 6.60, etc.). The high band returned papers at 8.0–8.5 (pure diffusion model theory, not topically comparable). **Initial bracket: 4.0–6.5.**

**Round 2 (narrowing):** Three queries on (a) "unpaired image translation medical imaging diffusion model evaluation" (3.5–6.5), (b) "fMRI super-resolution enhancement generative model" (4.5–7.0), (c) "Schrödinger bridge generative model image translation" (5.0–7.0). Read full reviews of X-Diffusion (5.50 avg, rejected), Scalable EUOT (5.60 avg, rejected), Variational Mirror Descent (6.80 avg, rejected), and revisited MindSimulator (5.75 avg, accepted poster).

**Comparison to anchors:**
- **MindSimulator (5.75, accepted poster):** Both papers use generative models for fMRI-related tasks. MindSimulator had stronger evaluation breadth (multiple downstream tasks, ablation) but similar concerns about confounds. The current paper has a more novel methodology (conformal mapping + SB) but weaker evidence for its central claim. The current paper is slightly weaker.
- **X-Diffusion (5.50, rejected):** Both papers tackle medical image enhancement with diffusion models. X-Diffusion was criticized for hallucination concerns and limited clinical relevance. The current paper has more realistic experimental design but similar evaluation gaps. Comparable quality.
- **Scalable EUOT (5.60, rejected):** Theoretical SB paper with solid methodology but limited evaluation. The current paper is more applied and has broader evaluation. Comparable.
- **LEA (3.00, rejected):** Serious presentation and methodology issues. The current paper is substantially stronger.

**Final score: 5.0.** The paper has genuine methodological novelty and shows consistent improvements across multiple experiments, which places it above the low-quality reject threshold. However, the missing ground-truth R̄² comparison for the central claim, the unexplained FID trade-off in the ablation, and the absence of error bars prevent it from being a clear accept. A revision addressing the ground-truth comparison and the FID trade-off discussion could raise this to a solid acceptance.

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>